Seattle Genetics Inc (NASDAQ:SGEN)

65.75
Delayed Data
As of 4:00pm ET
 +0.64 / +0.98%
Today’s Change
45.31
Today|||52-Week Range
69.71
+22.90%
Year-to-Date
No recent news for Seattle Genetics Inc.

Today’s Trading

Previous close65.11
Today’s open64.34
Day’s range63.61 - 65.88
Volume744,772
Average volume (3 months)984,148
Market cap$9.1B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+12.00%
Earnings growth (this year)-105.23%
Earnings growth (next 5 years)-28.70%
Revenue growth (last year)+15.33%
P/E ratioNM
Price/Sales15.88
Price/Book12.27

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc-0.39-0.98%
ALKSAlkermes Plc+0.47+0.93%
ALNYAlnylam Pharmaceutic...-1.57-1.46%
IONSIonis Pharmaceutical...-2.97-6.37%
Data as of 4:00pm ET, 06/18/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.41
Annual revenue (last year)$482.3M
Annual profit (last year)-$125.5M
Net profit margin-26.03%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Clay B. Siegall
CFO &
Principal Accounting Officer
Todd E. Simpson
Corporate headquarters
Bothell, Washington

Forecasts